tremelimumab

Italy

Drugs containing this active substance

  • IMJUDO

    It is an anticancer medicine that helps the immune system fight cancer. It is used to treat an advanced or unresectable type of liver cancer (hepatocellular carcinoma) in combination with durvalumab, and for advanced non-small cell lung cancer in combination with durvalumab and chemotherapy.

    Form: solution for infusion, concentrate

    Active substance Dosage
    tremelimumab -

    ATC: L01FX20

    Manufacturer: ASTRAZENECA AB